These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18991198)

  • 41. Zinc as a treatment for Wilson's disease--an orphan among orphans.
    Brewer GJ; Hill GM
    Prog Clin Biol Res; 1985; 197():143-56. PubMed ID: 4070288
    [No Abstract]   [Full Text] [Related]  

  • 42. Letter: Treatment of Wilson's disease.
    Bucur I; Hasselgren KH
    Lancet; 1975 Dec; 2(7946):1218. PubMed ID: 53713
    [No Abstract]   [Full Text] [Related]  

  • 43. [Interviews with a young boy with Wilson's disease. Relation of the patient with copper and the physicians].
    Aubry J
    Arch Fr Pediatr; 1967 Jan; 24(1):104-5. PubMed ID: 6031446
    [No Abstract]   [Full Text] [Related]  

  • 44. Cytopenias secondary to copper depletion complicating ammonium tetrathiomolybdate therapy for Wilson's disease.
    Karunajeewa H; Wall A; Metz J; Grigg A
    Aust N Z J Med; 1998 Apr; 28(2):215-6. PubMed ID: 9612534
    [No Abstract]   [Full Text] [Related]  

  • 45. Chelating agents in the treatment of hepatolenticular degeneration (Wilson's disease).
    BLATTNER RJ
    J Pediatr; 1958 Jun; 52(6):758-61. PubMed ID: 13550045
    [No Abstract]   [Full Text] [Related]  

  • 46. Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson's disease.
    Dixon HB; Gibbs K; Walshe JM
    Lancet; 1972 Apr; 1(7755):853. PubMed ID: 4111619
    [No Abstract]   [Full Text] [Related]  

  • 47. [MRI of Wilson's disease. Tissue differentiation of intracerebral lesions].
    Dörnemann H; Petsch R; Braitinger S
    Rofo; 1987 Nov; 147(5):570-1. PubMed ID: 2825298
    [No Abstract]   [Full Text] [Related]  

  • 48. [Association of an uncombable hair syndrome and Wilson's disease].
    Gonin J; Pepin B; Lévêque B; Guilaine J; Bonnefont JP
    Ann Pediatr (Paris); 1984 Apr; 31(4):311-5. PubMed ID: 6742703
    [No Abstract]   [Full Text] [Related]  

  • 49. 'Face of the giant panda' sign in Wilson's disease: revisited.
    Kuruvilla A; Joseph S
    Neurol India; 2000 Dec; 48(4):395-6. PubMed ID: 11146611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Metabolism of iron and copper, action of chelators and therapeutic possibilities in Wilson's disease and hemochromatosis].
    PIRART J
    Pathol Biol; 1961 May; 9():1157-74. PubMed ID: 13735975
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of Wilson's disease: the historical background.
    Walshe JM
    QJM; 1996 Jul; 89(7):553-5. PubMed ID: 8759497
    [No Abstract]   [Full Text] [Related]  

  • 52. Wilson's disease with extensive degeneration of cerebral white matter and cortex.
    Shimoji A; Miyakawa T; Watanabe K; Yamashita K; Katsuragi S; Kabashima K
    Jpn J Psychiatry Neurol; 1987 Dec; 41(4):709-17. PubMed ID: 3453418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiangiogenic therapy through copper chelation.
    Sproull M; Brechbiel M; Camphausen K
    Expert Opin Ther Targets; 2003 Jun; 7(3):405-9. PubMed ID: 12783576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Wilson's disease].
    Martin-Duverneuil N; De Broucker T
    Rev Neurol (Paris); 2001 Jan; 157(1):119-21. PubMed ID: 11240557
    [No Abstract]   [Full Text] [Related]  

  • 55. CT hypodensity on cerebral white matter in Wilson's disease.
    Jardim LB; Carneiro A; Hansel S; Rieder CR; Giugliani R
    Arq Neuropsiquiatr; 1991 Jun; 49(2):211-4. PubMed ID: 1810242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Schizophrenia and Wilson's disease].
    Saint-Laurent M
    Can J Psychiatry; 1992 Jun; 37(5):358-60. PubMed ID: 1353405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical, CT and evoked potential manifestations in Wilson's disease with cerebral white matter involvement.
    Chu NS
    Clin Neurol Neurosurg; 1989; 91(1):45-51. PubMed ID: 2538281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnetic resonance imaging of the brain in Wilson's disease.
    Thuomas KA; Aquilonius SM; Bergström K; Westermark K
    Neuroradiology; 1993; 35(2):134-41. PubMed ID: 8433789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wilson's disease: neurological and magnetic resonance imaging improvement on zinc treatment.
    Heckmann JM; Eastman RW; De Villiers JC; Hewlett R
    J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1273-4. PubMed ID: 7931398
    [No Abstract]   [Full Text] [Related]  

  • 60. Current Biomedical Use of Copper Chelation Therapy.
    Baldari S; Di Rocco G; Toietta G
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.